One-Year Results of the SELUTION DeNovo Trial Comparing a Strategy of PCI with a Sirolimus-eluting Balloon and Provisional Stenting Versus Systematic DES Implantation to Treat DeNovo Coronary Lesions

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - French Ministry of Health; CERC</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Techwald; Sanofi; Novartis</li><li> - Sonivie; Valcare</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation</li><li>Equity/Stock(s)/Options - MedAlliance; Sonivie</li></ul>